Propofol
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Propofol is used to treat delirium, pain, psychomotor agitation and status epilepticus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 2, 1989, and the first generic was approved Jan 4, 1999. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient.
Propofol is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $0.17 to $0.17 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$0.17 – $0.17
per ML
7d Activity
avg -1.2% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing PROPOFOL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PROPOFOL 200 MG/20 ML VIAL | $0.1709 per ML | -1.17% |
PROPOFOL 200 MG/20 ML VIAL | $0.1709 per ML | -1.17% |
Frequently Asked Questions
What is Propofol used to treat?
Propofol is used to treat delirium, pain, psychomotor agitation and status epilepticus, per the National Library of Medicine's MED-RT classification.
When did Propofol become available as a generic?
FDA approved the first generic Propofol (ANDA) on Jan 4, 1999. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Propofol products are on the market?
The Propofol drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Propofol?
NADAC reference prices for Propofol range from $0.1709 to $0.1709 per ML.
Which manufacturers make Propofol?
2 manufacturers list Propofol in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (1), Sagent Pharmaceuticals (1).
How has the price of Propofol changed recently?
Over the past 7 days, 0 Propofol NDCs rose and 2 fell, with a market-wide average change of -1.2%.